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Varieties of in vitro systems have been used to study biochemical properties of
human immunodeficiency virus Gag-capsid protein (HIV Gag-CA). Recently, we have
comparatively characterized HIV-1 and HIV-2 Gag-CA proteins using such technology,
and have demonstrated that the NaCl-initiated CA-polymerization in vitro and the
stability of CA N-terminal domain as judged by differential scanning fluorimetry (DSF) are
inversely correlated. In this study, we found that ZnCl2 works as a competent initiator
of the in vitro HIV-1 CA-polymerization at much lower concentrations than those of
NaCl frequently used for the polymerization initiation. We also showed by DSF assays
that ZnCl2 highly destabilize HIV-1 CA. Furthermore, PF74, a well-known inducer of
premature HIV-1 uncoating in infected cells, was demonstrated to unusually promote
the HIV-1 CA-disassembly in the presence of ZnCl2 as revealed by DSF assays. Taken
together, we conclude that the DSF method may be useful as an efficient monitoring
system to screen anti-HIV-1 CA molecules.
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INTRODUCTION
Functional core structure consisting of numerous capsid (CA) proteins is a major component
of viral particles and is essential for the replication of human immunodeficiency virus type 1
(HIV-1) (Freed and Martin, 2013; Campbell and Hope, 2015; Yamashita and Engelman, 2017).
As well-documented, Gag-CA plays critical multiple roles at various steps in the HIV-1 life cycle.
It needs to be underscored that the biological and/or biochemical analysis from different angles
of this multi-functional viral protein is a prerequisite to understand the virology of HIV-1 with a
complicated replication mode.
Disassembly and assembly processes of Gag-CA in cells are definitely vital for HIV-1, and can
be analyzed by in vitro systems using the purified proteins produced in bacteria (Ehrlich et al.,
1992; Li et al., 2000; Ganser-Pornillos et al., 2004; Barklis et al., 2009; Miyazaki et al., 2017).
In our previous study, we have demonstrated the NaCl-dependent increase in HIV-1 Gag-CA
polymerization/assembly and also in HIV-1 Gag-CA N-terminal domain (NTD) instability
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(Miyazaki et al., 2017). In the work, we employed the turbidity
and fluorescence-based thermal shift assays to monitor Gag-
CA assembly and Gag-CA NTD stability, respectively (Miyazaki
et al., 2017). Although Gag-CA self-assembly could be induced
by NaCl, a high concentration (1–2 M) was required to initiate
the reaction, being a potential obstacle to smoothly perform
various experiments. The thermal shift assay, i.e., the differential
scanning fluorimetry (DSF), makes use of different fluorescence
intensities from the target protein differentially bound with
SYPRO orange (Invitrogen) by heat denaturation. This DSF
method could be applicable to various studies, and notably,
is suitable for large-scale handlings of the samples. In the
present study, we found that ZnCl2 can effectively induce
Gag-CA polymerization with much lower concentrations relative
to NaCl. We also showed by DSF assays that a small molecule
with a known anti-CA property indeed gives an effect on the
CA-stability, consistent with the anti-viral activity. We propose
here that the DSF system can be applicable for searching for
anti-HIV-1 CA antivirals.
ZnCl2 PROMOTES POLYMERIZATION OF
HIV-1 CA AND DESTABILIZES ITS NTD
In this study, we always used histidine-tagged Gag-CA (Miyazaki
et al., 2017), derived from an infectious clone of HIV-1 designated
NL4-3 (Adachi et al., 1986), as the experimental material. We
have previously analyzed the in vitro assembly property of
HIV-1 CA mediated by high concentrations of NaCl (Miyazaki
et al., 2017). In mature HIV-1 virions, four cleaved forms of
Gag proteins, namely, matrix (MA), CA, nucleocapsid (NC),
and p6, are present in close proximity (Freed and Martin,
2013). Because of the nature of these Gag mature products, we
examined the effect of NC, which contains two zinc-binding
motif (Freed and Martin, 2013), on the polymerization and
thermal stability HIV-1 Gag-CA. During the study, we noticed
that ZnCl2 could promote the HIV-1 Gag-CA assembly in vitro.
We therefore asked whether the CA-polymerization is dependent
on ZnCl2 concentrations. Polymerization process was monitored
by measuring the optical density (OD) of the reaction at 350 nm
using a spectrophotometer (NanoDrop 1000, Thermo Fisher
Scientific). As shown in Figure 1A, although the reactions with
10 and 20 µM CA gave a plateau at relatively high concentrations
of ZnCl2, the polymerization with 50 µM CA proceeded linearly
with respect to the ZnCl2 concentrations up to 100 µM. This
result is a sharp contrast to the previous data of the NaCl-initiated
polymerization assays, in which at least 106 µM NaCl was
required to detect a significant level of polymerized products
(Miyazaki et al., 2017). Although the molecular basis for this
difference remains to be determined, it is conceivable that the
polymerization could be efficiently triggered through enhanced
complex formation of histidine-tagged CA by Zn2+. In any case,
it is clear that ZnCl2 is a better reagent than NaCl to set up
experiments here.
We then compared the thermal stability of NL4-3 CA NTD
in the presence (100 µM) and absence of ZnCl2 by the DSF
method using SYPRO orange as described before (Niesen et al.,
2007; Fedorov et al., 2012; Miyazaki et al., 2017). SYPRO orange
binds to hydrophobic patches of the test protein exposed by
heat treatment (Figure 1B). As can be seen, the extent of
heat denaturation, i.e., the thermal stability of the protein, is
quantitatively estimated by the fluorescence intensity (FI) from
SYPRO orange bound to the protein. Figure 1C shows the
actual results of the assay. From the FI and peak temperatures
in the melt curves that are calculated by the difference in
FI at each temperature (dFI/dT), the Tm values (melting
temperature) for CA-NTD at zero and 100 µM of ZnCl2 were
found to be 74.1 and 54.8◦C, respectively. Thus, consistent with
the enhancement of CA-polymerization, ZnCl2 destabilized the
CA-NTD very efficiently at much lower concentrations, again
in contrast to the effective concentrations reported for NaCl
(Miyazaki et al., 2017).
SYSTEM TO SEARCH FOR ANTI-CA
MOLECULES
Together with the data here (Figure 1C) and our previous
results (Miyazaki et al., 2017), we could propose a new system
based on the DSF assay to screen or identify molecules that
aberrantly destabilize or stabilize HIV-CA NTD, a rate-limiting
viral factor for the CA-polymerization (Lingappa et al., 2014).
DSF system can be used as a simple and rapid method to search
for small molecule modulators of CA assembly. We routinely
use a real-time PCR machine such as the 7500 system (Applied
Biosystems) to perform DSF assays to assure that large numbers
of test samples can be automatically handled in a short time.
Figure 2A depicts a schema to explain the basis for the method
(Figure 1C) (Miyazaki et al., 2017). In a control, i.e., in the
absence of any molecules with anti-CA assembly, CA exhibits its
own thermal stability as revealed by FI (curve 2) and dFI/dT.
If some test molecules are present in the FI monitoring assay
system that relatively destabilize (curve 1: promote assembly) or
stabilize (curve 3: promote disassembly) the CA-NTD protein
as compared to a negative control, decreased (curve 1) or
increased (curve 3) Tm-shift would be expected. Because the
FI curves simply reflect the SYPRO orange-binding status of
the test proteins (Figure 1B), basal levels of the FI values
would be variable somewhat under conditions used. However,
these variations intrinsically have no effects on the Tm value
itself.
To verify the above working hypothesis, we have selected PF74
that was recently reported to be an effective anti-HIV-CA small
molecule, and assessed its activity against HIV-1 CA by the DSF
assay. PF74 has been precisely analyzed by both in vitro and
in vivo experiments for its anti-virus activity and the underlying
molecular mechanism (Blair et al., 2010; Shi et al., 2011, 2015;
Bhattacharya et al., 2014; Lad et al., 2015). PF74 binds to
HIV-1 CA-NTD and promotes the assembly of the CA proteins
in vitro (Blair et al., 2010; Bhattacharya et al., 2014; Lad et al.,
2015), whereas it destabilizes assembled CA proteins (Shi et al.,
2011). These seemingly paradoxical results can likely be explained
by a notion that PF74 acts against HIV-1 replication through
aberrantly destabilizing higher-order structures of CA proteins,
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FIGURE 1 | Assembly and thermal stability of NL4-3 Gag-CA. (A) Polymerization of Gag-CA. Length for polymerization reactions was 4 h as previously described
(Miyazaki et al., 2017). Polymerized products were monitored by OD at 350 nm using a spectrophotometer (NanoDrop 1000, Thermo Fisher Scientific). (B) A
schema for the DSF method. FI curve is illustrated by SYPRO orange FI values from various states of the test protein. (C) Thermal stability of NL4-3 Gag-CA NTD.
This was determined as previously described (Miyazaki et al., 2017). SYPRO orange FI at different temperatures was monitored by 7500 real-time PCR system
(Applied Biosystems), and melt curves were calculated by differences in FI at each temperature (dFI/dT). Peak temperatures in dFI/dT curves represent Tm. The
experiments in (A,C) were repeated with similar results.
FIGURE 2 | Thermal stability curves of NL4-3 Gag-CA NTD. (A) Schematic representation of the stability curves. Curves 1 and 3 show the results in the presence of
molecules relatively destabilizing and stabilizing CA-NTD protein, respectively, compared to a control (curve 2, in the absence of any molecules interfering with the
CA-assembly). This schema is depicted based upon the assumption that FI values are similarly minimal at lower temperatures and increase/decrease similarly at
higher temperatures under various conditions. (B,C) Thermal stability of Gag-CA NTD in the absence and presence of PF74 (75 µM). The curves obtained for
reactions with ZnCl2 (100 µM) or NaCl (100 µM) are shown in (B,C), respectively, as indicated. SYPRO orange FI at different temperatures was monitored by 7500
real-time PCR system (Applied Biosystems), and melt curves were calculated by differences in FI at each temperature (dFI/dT). Peak temperatures in dFI/dT curves
represent Tm. The results in (B,C) were reproduced in experiments using lower concentrations of PF74 (25 and 50 µM).
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i.e., the core-like structures, observed in vitro (Ehrlich et al.,
1992; Li et al., 2000; Ganser-Pornillos et al., 2004; Barklis et al.,
2009; Miyazaki et al., 2017). Indeed, the capsid structure in cells
and virions was found to be affected by PF74 (Blair et al., 2010;
Shi et al., 2011; Bhattacharya et al., 2014). Consistent with the
above thought, in vivo analyses at a cellular level have shown
that PF74 does not affect virus production but makes nascent
virions virtually non-infectious (Blair et al., 2010; Shi et al., 2011).
Furthermore, it has been revealed that PF74 targets an early virus
replication phase, probably the viral uncoating step (Blair et al.,
2010; Shi et al., 2011). Collectively, it is rational to conclude that
PF74 exerts its anti-HIV-1 effect at the early viral replication
stage to inhibit the reverse transcription of viral genomic RNA in
infected cells. Thus, PF74 promotes premature virus uncoating,
exhibiting an anti-HIV-1 activity similar to that of a cellular anti-
viral restriction factor designated TRIM5α (Malim and Bieniasz,
2012; Nakayama and Shioda, 2015). Of note here, in our in vitro
DSF system, both the assembly and disassembly of HIV-1 CA-
NTD proteins could occur. The data obtained by this system
would represent the resultant sum of both processes.
As shown in Figure 2B, PF74 (75 µM) shifted the Tm
as seen for curve 3 in Figure 2A. Based on Tm values with
and without PF74, 60.9 and 55.4◦C, respectively, we concluded
that it enhances the CA-disassembly. This observation was
compatible with the findings summarized above (Blair et al.,
2010; Shi et al., 2011; Bhattacharya et al., 2014). In a concurrent
experiment, we also determined whether PF74 affects the stability
of HIV-1 CA-NTD in the presence of NaCl (100 µM). As
readily seen in Figure 2C, no appreciable difference in the
Tm values with and without PF74 was detected (76.2 and
76.6◦C, respectively). Therefore, the result in Figure 2B may
be significant, since the Tm-shift was observed only when
the CA-polymerization could occur. While ZnCl2 (100 µM)
efficiently induced the CA-assembly (Figure 1A), NaCl (100 µM)
did not initiate the process at all (Miyazaki et al., 2017). In total,
we provided experimental evidence to show that our DSF system
consisting of HIV-1 CA-NTD and fluorescence-based thermal
shift assay is useful for screening anti-HIV-1 molecules targeting
its CA.
CONCLUDING REMARKS
In pilot experiments, we have successfully used a
high-throughput screening method, i.e., the DSF assay, to
explore for anti-HIV-1 CA small molecules (Figures 1, 2). In
the assay system, HIV-1 CA-NTD protein (50 µM) is prepared
in 50 mM Tris–HCl (pH 8.0), 100 µM ZnCl2, and 1 mM
2-mercaptethanol containing SYPRO orange, and analyzed
through a temperature gradient (25–95◦C) using a real-time
PCR machine (Niesen et al., 2007; Fedorov et al., 2012; Miyazaki
et al., 2017). The turbidity assay of CA assembly can also
be developed into a high-throughput screening method, but
the DSF system has the clear advantage over it. The DSF
method is more sensitive than the turbidity assay, and gives
more quantitative and reproducible data to select molecules
with unusually CA-destabilizing or -stabilizing activity. Our
DSF system is simple, and all reagents including the CA-NTD
protein are readily available. Although this method is promising,
it is absolutely necessary to test large numbers of molecules
against HIV-1 CA, and to find certain candidates deserve
evaluation of their inhibitory effects on the HIV-1 replication
in cells.
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